Evaluation of the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Aficamten in Healthy Japanese and Caucasian Participants

Cytokinetics Incorporated published this content on September 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 20, 2025 at 23:57 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]